RALEIGH, N.C.--(BUSINESS WIRE)--BioDelivery Sciences International, Inc. (Nasdaq: BDSI), a specialty pharmaceutical company focused on developing innovative products to address growing market opportunities using its proprietary drug delivery technologies, today announced that Mark A. Sirgo, Pharm.D., President and Chief Executive Officer will present at the upcoming ROTH Capital Partners 21st Annual Orange County Growth Stock Conference.
